Stirlingshire Investments, Inc.

Position in LLY — ELI LILLY & Co

CIK 1829271 NEW YORK, NY

Position in LLY

as of Jun 30, 2026 · filed Jul 31, 2026 Compact

Position Value

$346,635

+$71,624 QoQ

Shares Held

289

-3.3% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.77%

of 13F equity value

Holder Rank

#4,054

of 4,605 holders

Holding Since

Dec 2025

3 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Stirlingshire Investments, Inc. holds $1,780,387 across 5 Drug Manufacturers - General names. LLY ranks #3 (19.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	1,998	$507,432
2	MRK	Merck & Co., Inc.	2,923	$375,605
3	LLY	ELI LILLY & Co This page	289	$346,635
4	NVS	Novartis AG	1,979	$310,148
5	ABBV	AbbVie Inc.	956	$240,567

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$346,635	289	-3.3%	Shares	Sole	2026-07-31
2026-03-31	$275,011	299	+22.5%	Shares	Sole	2026-05-04
2025-12-31	$262,221	244	—	Shares	Sole	2026-02-11
No filing history on record for this holder in this stock.